Medindia LOGIN REGISTER
Medindia
Advertisement

Mutated Huntington's Disease Gene Silenced by Novel RNAi Therapy

by Kathy Jones on May 22, 2014 at 4:16 PM
 Mutated Huntington's Disease Gene Silenced by Novel RNAi Therapy

New research suggests that a targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, which is the cause of Huntington's disease. The latter is a fatal, inherited neurodegenerative disorder.

The effectiveness of this RNA interference (RNAi) approach in reducing levels of mutant Htt protein and disease symptoms in a mouse model of the disease is described in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Human Gene Therapy website.

Advertisement

Lisa Stanek and coauthors from Genzyme (Framingham, MA) used an adeno-associated viral (AAV) vector to deliver a targeted nucleic acid sequence called a small interfering RNA (siRNA) into the cells of affected mice. The siRNA selectively binds to the mutated gene, blocking disease-causing Htt production. The authors present data demonstrating the ability to deliver the therapeutic RNAi into the cells, reduce mutant Htt levels, and impact behavioral deficits in the mice without causing any noticeable neurotoxicity, in their article "Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease."

"The Genzyme group uses state-of-the-art delivery technology and a gene silencing approach to generate very promising preclinical data for Huntington's disease," says James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Genetics & Stem Cells News

Early-Stage Stem Cell Trial for Progressive Multiple Sclerosis
Among MS patients, the stem cells showed a neuroprotective role, guarding nerve cells from further decline.
Human Genetics Unravels Mysteries of Digestive Disorders
New possibilities for research on digestive diseases have been set by complete decoding of the Y chromosome.
World's First CRISPR-Based Gene Therapy for Blood Disorders
UK has given the green light to the world's inaugural gene therapy for sickle-cell disease and thalassemia.
Genotype Linked to Short-Lifespan Affects 1 in 25 People
1 in 25 people had a genotype linked to short lifetime, which includes BRCA2 and LDLR genes, that reduced lifespan by seven years, and six years respectively.
Is Stem Cell Therapy a Breakthrough for Reversing Osteoarthritis?
The study findings help redefine osteoarthritis as a reversible loss of key cartilage stem cells, not just 'wear and tear'."
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Mutated Huntington's Disease Gene Silenced by Novel RNAi Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests